In vitro evaluation of osteoblastic differentiation on amorphous calcium phosphate-decorated poly(lactic-co-glycolic acid) scaffolds

Journal of Tissue Engineering and Regenerative Medicine

Volumn 5, Issue 10, 2011, Pages 780-789

  Popp, Jenni R ^a   Laflin, Kate E ^b   Love, Brian J ^a,b   Goldstein, Aaron S ^a,b  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^b State University   (United States)

Author keywords

Alkaline phosphatase; Differentiation; Hydroxyapatite; MC3T3 E1 cells

Indexed keywords

BIOSYNTHESIS; BONE; CELL ENGINEERING; CYTOLOGY; ENDOTHELIAL CELLS; HYDROXYAPATITE; IONS; OSTEOBLASTS; PHOSPHATASES; SCAFFOLDS (BIOLOGY); SOLUTIONS; ZIRCONIA;

ALKALINE PHOSPHATASE; ALKALINE PHOSPHATASE ACTIVITY; AMORPHOUS CALCIUM PHOSPHATE; CALCIUM PHOSPHATE MINERALS; CELL NUMBER; DIFFERENTIATION; MC3T3-E1; MC3T3-E1 CELL; MRNA EXPRESSION; OSTEOPONTIN;

CALCIUM PHOSPHATE;

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 4; CALCIUM PHOSPHATE; HYDROXYAPATITE; MESSENGER RNA; OSTEOCALCIN; OSTEOPONTIN; POLYGLACTIN; PROSTAGLANDIN E2; SIALOPROTEIN; TRANSCRIPTION FACTOR OSTERIX; VASCULOTROPIN; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; CELL ADHESION; CELL COUNT; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; ENZYME ACTIVITY; IN VITRO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS;

EID: 80054775074     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.376     Document Type: Article

References (55)

1. Alliot-Licht B, Gregoire M, Orly I, et al. 1991; Cellular activity of osteoblasts in the presence of hydroxyapatite: an in vitro experiment. Biomaterials 12: 752-576.
2. Bashur CA, Dahlgren LA, Goldstein AS. 2006; Effect of fiber diameter and orientation on fibroblast morphology and proliferation on electrospun poly(D, L-lactic-co-glycolic acid) meshes. Biomaterials 27: 5681-5688.
3. Batzer R, Liu Y, Cochran DL, et al. 1998; Prostaglandins mediate the effects of titanium surface roughness on MG63 osteoblast-like cells and alter cell responsiveness to 1α, 25-(OH)2D3. J Biomed Mater Res 41: 489-496.
4. Bilezikian JP, Raisz LG, Rodan GA. 2002; Principles of Bone Biology. Academic Press: San Diego, CA.
5. Chang YL, Stanford CM, Keller JC. 2000; Calcium and phosphate supplementation promotes bone cell mineralization: implications for hydroxyapatite (HA)-enhanced bone formation. J Biomed Mater Res 52: 270-278.
6. De Long WG Jr, Einhorn TA, Koval K, et al. 2007; Bone grafts and bone graft substitutes in orthopaedic trauma surgery. A critical analysis. J Bone Joint Surg Am 89: 649-658.
7. Eanes ED. 2001; Amorphous calcium phosphate. Monogr Oral Sci 18: 130-147.
8. Eberle J, Schmidmayer W, Erben RG, et al. 1999; Skeletal effects of zinc deficiency in growing rats. J Trace Elem Med Biol 13: 21-26.
9. Evans EJ. 1991; Toxicity of hydroxyapatite in vitro: the effect of particle size. Biomaterials 12: 574-576.
10. Fellah BH, Delorme B, Sohier J, et al. 2010; Macrophage and osteoblast responses to biphasic calcium phosphate microparticles. J Biomed Mater Res 93A: 1588-1595.
11. Franceschi RT, Iyer BS. 1992; Relationship between collagen synthesis and expression of the osteoblast phenotype in MC3T3-E1 cells. J Bone Miner Res 7: 235-246.
12. Goldstein AS. 2001; Effect of seeding osteoprogenitor cells as dense clusters on cell growth and differentiation. Tissue Eng 7: 817-827.
13. Hidaka S, Okamoto Y, Abe K. 1994; Elutions of metal ions from dental casting alloys and their effect on calcium phosphate precipitation and transformation. J Biomed Mater Res 28: 175-180.
14. Hirata M, Kobayashi M, Takita M, et al. 2009; Hyaluronan inhibits bone resorption by suppressing prostaglandin E synthesis in osteoblasts treated with interleukin-1. Biochem Biophys Res Commun 381: 139-143.
15. Huang YC, Kaigler D, Rice KG, et al. 2005; Combined angiogenic and osteogenic factor delivery enhances bone marrow stromal cell-driven bone regeneration. J Bone Miner Res 20: 848-857.
16. Ikeuchi M, Ito A, Dohi Y, et al. 2003; Osteogenic differentiation of cultured rat and human bone marrow cells on the surface of zinc-releasing calcium phosphate ceramics. J Biomed Mater Res A 67: 1115-1122.
17. Jung G-Y, Park Y-J, Han J-S. 2010; Effects of HA released calcium ion on osteoblast differentiation. J Mater Sci Mater Med 21: 1649-1654.
18. Kajii T, Suzuki K, Yoshikawa M, et al. 1999; Long-term effects of prostaglandin E2 on the mineralization of a clonal osteoblastic cell line (MC3T3-E1). Arch Oral Biol 44: 233-241.
19. 2 stimulates the formation of mineralized bone nodules by a cAMP-independent mechanism in the culture of adult rat calvarial osteoblasts. J Cell Biochem 73: 36-48.
20. Kavlock KD, Pechar TW, Hollinger JO, et al. 2007; Synthesis and characterization of segmented poly(esterurethane urea) elastomers for bone tissue engineering. Acta Biomater 3: 475-484.
21. Kieswetter K, Schwartz Z, Hummert TW, et al. 1996; Surface roughness modulates the local production of growth factors and cytokines by osteoblast-like MG-63 cells. J Biomed Mater Res 32: 55-63.
22. Kreke MR, Goldstein AS. 2004; Hydrodynamic shear stimulates osteocalcin expression but not proliferation of bone marrow stromal cells. Tissue Eng 10: 780-788.
23. Kreke MR, Sharp LA, Lee YW, et al. 2008; Effect of intermittent shear stress on mechanotransductive signaling and osteoblastic differentiation of bone marrow stromal cells. Tissue Eng A 14: 529-537.
24. Kwak HB, Sun HM, Ha H, et al. 2008; Tanshinone IIA suppresses inflammatory bone loss by inhibiting the synthesis of prostaglandin E2 in osteoblasts. Eur J Pharmacol 601: 30-37.
25. Lee KY, Park M, Kim HM, et al. 2006; Ceramic bioactivity: progresses, challenges and perspectives. Biomed Mater 1: R31-37.
26. Liu H, Slamovich EB, Webster TJ. 2006; Increased osteoblast functions among nanophase titania/poly(lactide-co-glycolide) composites of the highest nanometer surface roughness. J Biomed Mater Res A 78: 798-807.
27. -ΔΔCT method. Methods 25: 402-408.
28. Lohmann CH, Dean DD, Koster G, et al. 2002; Ceramic and PMMA particles differentially affect osteoblast phenotype. Biomaterials 23: 1855-1863.
29. Ma PX, Zhang R, Xiao G, et al. 2001; Engineering new bone tissue in vitro on highly porous poly(α-hydroxyl acids)/hydroxyapatite composite scaffolds. J Biomed Mater Res 54: 284-293.
30. Ma S, Yang Y, Carnes DL, et al. 2005; Effects of dissolved calcium and phosphorous on osteoblast responses. J Oral Implantol 31: 61-67.
31. Maeno S, Niki Y, Matsumoto H, et al. 2005; The effect of calcium ion concentration on osteoblast viability, proliferation and differentiation in monolayer and 3D culture. Biomaterials 26: 4847-4855.
32. Martin JY, Schwartz Z, Hummert TW, et al. 1995; Effect of titanium surface roughness on proliferation, differentiation, and protein synthesis of human osteoblast-like cells (MG63). J Biomed Mater Res 29: 389-401.
33. Mayer H, Bertram H, Lindenmaier W, et al. 2005; Vascular endothelial growth factor (VEGF-A) expression in human mesenchymal stem cells: autocrine and paracrine role on osteoblastic and endothelial differentiation. J Cell Biochem 95: 827-839.
34. Murphy S, Wren AW, Towler MR, et al. 2010; The effect of ionic dissolution products of Ca-Sr-Na-Zn-Sibioactive glass on in vitro cytocompatibility. J Mater Sci Mater Med (in press).
35. Nakashima K, Zhou X, Kunkel G, et al. 2002; The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108: 17-29.
36. Ogata K, Imazato S, Ehara A, et al. 2005; Comparison of osteoblast responses to hydroxyapatite and hydroxyapatite/soluble calcium phosphate composites. J Biomed Mater Res A 72: 127-135.
37. Okamoto Y, Hidaka S. 1994; Studies on calcium phosphate precipitation: effects of metal ions used in dental materials. J Biomed Mater Res 28: 1403-1410.
38. Osborn JF, Newesely H. 1980; The material science of calcium phosphate ceramics. Biomaterials 1: 108-111.
39. Park H, Yim M. 2007; Rolipram, a phosphodiesterase 4 inhibitor, suppresses PGE2-induced osteoclast formation by lowering osteoclast progenitor cell viability. Arch Pharm Res 30: 486-492.
40. Popp JR, Laflin KE, Love BJ, et al. 2010; Fabrication and characterization of poly(lactic-co-glycolic acid) microsphere/ amorphous calcium phosphate scaffolds. J Tissue Eng Regen Med (in press).
41. Quarles LD, Yohay DA, Lever LW, et al. 1992; Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: an in vitro model of osteoblast development. J Bone Miner Res 7: 683-692.
42. 2 production in MC3T3-E1 cells. Connect Tissue Res 51: 150-158.
43. Schmitz JP, Hollinger JO, Milam SB. 1999; Reconstruction of bone using calcium phosphate bone cements: a critical review. J Oral Maxillofac Surg 57: 1122-1126.
44. Sharp LA, Lee YW, Goldstein AS. 2009; Effect of low-frequency pulsatile flow on expression of osteoblastic genes by bone marrow stromal cells. Ann Biomed Eng 37: 445-453.
45. Storrie H, Stupp SI. 2005; Cellular response to zinc-containing organoapatite: an in vitro study of proliferation, alkaline phosphatase activity and biomineralization. Biomaterials 26: 5492-5499.
46. Suda M, Tanaka K, Natsui K, et al. 1996; Prostaglandin E receptor subtypes in mouse osteoblastic cell line. Endocrinology 137: 1698-1705.
47. Sun JS, Tsuang YH, Liao CJ, et al. 1997; The effects of calcium phosphate particles on the growth of osteoblasts. J Biomed Mater Res 37: 324-334.
48. Tenenbaum HC. 1981; Role of organic phosphate in mineralization of bone in vitro. J Dent Res 60: 1586-1589.
49. Tenenbaum HC, Heersche JN. 1982; Differentiation of osteoblasts and formation of mineralized bone in vitro. Calcif Tissue Int 34: 76-79.
50. Tu Q, Valverde P, Chen J. 2006; Osterix enhances proliferation and osteogenic potential of bone marrow stromal cells. Biochem Biophys Res Commun 341: 1257-1265.
51. Tu Q, Valverde P, Li S, et al. 2007; Osterix overexpression in mesenchymal stem cells stimulates healing of critical-sized defects in murine calvarial bone. Tissue Eng 13: 2431-2440.
52. Webster TJ, Ergun C, Doremus RH, et al. 2000; Enhanced functions of osteoblasts on nanophase ceramics. Biomaterials 21: 1803-1810.
53. 2 in osteoblastic cell lines and adult rat bone tissue. Bone 28: 275-281.
54. Whited BM, Skrtic D, Love BJ, et al. 2005; Osteoblast response to zirconia-hybridized pyrophosphate-stabilized amorphous calcium phosphate. J Biomed Mater Res A 76A: 596-604.
55. Yoon ST, Boden SD. 2002; Osteoinductive molecules in orthopaedics: basic science and preclinical studies. Clin Orthop Relat Res 395: 33-43.